ArticleAnnals of the rheumatic diseases2019

Response to: 'Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series' by Narváez.

Dinesh Khanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.